NCT00996593
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
Not specified
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
1,630 public trials
214 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT02782845
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Bogotá, Colombia
- Chihuahua City, Mexico
- Chihuahua City, Mexico
- Estado de México, Mexico
NCT00825149
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Kogarah, New South Wales, Australia
- Sydney, New South Wales, Australia
- Greenslopes, Queensland, Australia
- Woolloongabba, Queensland, Australia
NCT02199288
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Eskilstuna, Sweden
- Halmstad, Sweden
- Helsingborg, Sweden
- Linköping, Sweden
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
- Locations
-
- Stanford, California, United States
- Denver, Colorado, United States
- Washington D.C., District of Columbia, United States
- Boston, Massachusetts, United States
Completed
A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma
NCT01392716
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Angers, France
- Besançon, France
- Bordeaux, France
- Clamart, France
NCT00876122
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Sutton, United Kingdom
NCT00854152
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Chicago, Illinois, United States
- Boston, Massachusetts, United States
- New York, United States
- Nashville, Tennessee, United States
Completed
A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma
NCT01388959
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Toulouse, France
NCT00854126
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Boston, Massachusetts, United States
- Villejuif, France
- Manchester, United Kingdom